Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli

Clinical Nephrology

Volumn 53, Issue 5, 2000, Pages 319-324

  Kamitsuji, H ^a   Nonami, K ^a   Murakami, T ^a   Ishikawa, N ^a   Nakayama, A ^a   Umeki, Y ^a  

^a NARA MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hemolytic uremic syndrome; Tissue factor; Verotoxin

Indexed keywords

THROMBOMODULIN; THROMBOPLASTIN; VEROTOXIN;

ARTICLE; BLOOD CLOTTING; CHILD; CHRONIC KIDNEY FAILURE; ENDOTHELIUM CELL; ENTEROBACTER INFECTION; FEMALE; GASTROENTERITIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; MALE; PATHOGENESIS; THROMBOSIS;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; LIPOPROTEINS; MALE; SHIGA TOXINS; THROMBOPLASTIN;

EID: 0034024774     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Akashi S, Joh K, Tsuji A, Hoshi H, Hayakawa T, Mara J, Abe T, Hatoni M, Mori T 1994 A severe outbreak of haemorrhagic colitis and hemolytic uremic syndrome associated with Escherichia coli O157:H7 in Japan. Eur J Pediatr 153: 650-655
2. Ameri A, Kuppuswamy MN, Basu S, Bajaj SP 1992 Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood 71: 259-262
3. Bevilaacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA 1984 Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothclial cells. J Exp Med 160: 618-623
4. Colasanti G, Maroger LM, D'Amico G 1987 Deposition of fibrin-stabilizing factor (FXIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (FVIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy. Clin Nephrol 28: 28-34
5. Conkling PR, Greenberg CS, Weinberg JB 1988 Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U 937 and peripheral blood monocytes. Blood 72: 128-113
6. Drake TA, Cheng J, Chang A, Taylor FB Jr 1933 Expression of tissue factor thrombomodulin, and E-selectin in baboons with lethal Eschericia coli sepsis. Am J Pathol 142: 1458-1470
7. Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Genshini GF, Serneri GGN 1998 Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemostas 79: 495-499
8. Griffin PM, Tauxe RV 1991 The epidemiology of infection caused by Escherichia coli OI57:H7, other entero-hemorrhagic Escherichia coli and the associated hemolytic uremic syndrome. Epidemiol Rev 13: 60-98
9. Hoyer JR, Michael AF, Hoyer LW 1974 Immunofluorescent localization on antihemophilic factor antigen and fibrinogen in human renal diseases. J Clin Invest 53: 1375-1384
10. Ishii H, Uchiyama H, Kazama N 1991 Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemostas 65: 618-623
11. Karmali MA, Petric M, Lim C, Fleming PC, Arbux GS, Lior H 1985 The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151: 775-782
12. Moore KL, Andoreoli SP, Esmon NL, Esmon CT, Bang NU 1987 Endotoxin enhances tissue factor and supresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 79: 124-130
13. Nakamura S, Kamikubo Y, Okajima K, Asakura H, Nakamura K 1993 Plasma tissue factors; its sensitive assay and characterization. Thromb Haemostas 69: 744
14. Nawroth PP, Stern DM 1986 Modulation of endothelial cell hemostasis properties by tumor necrosis factor. J Exp Med 163: 740-745
15. Nemerson Y 1995 Tissue factor: Then and now. Thromb Haemostas 74: 180-184
16. Novotny WF, Brown SG, Mileitich JP, Rader DJ, Broze Jr GJ 1991 Plasma antigen levels of the lipoprotein-associated inhibitor in patient samples. Blood 78: 387-393
17. Ogawa I, Ohi H, Fujita T, Kamnatsuse K 1996 Elevation of plasma thrombomodulin levels in any glomerulonephritis with heavy proteinuria. Jpn J Nephrol 38: 300-304
18. Osterud B, Bajaj MS, Bajaj SP 1995 Site of tissue factor pathway inhibitor (TFP1) and tissue factor expression under physiologic and pathologic conditions. Thromb Haemostas 73: 873-875
19. Pelzer H, Schwarz A, Heimburger N 1988 Determination of thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 59: 101-105
20. Rapoport SI, Rao VM 1995 The tissue factor pathway: How it has become a "prime ballerina". Thromb Haemostas 74: 7-17
21. Rowe PC, Orrbine E, Lior H, Welles GA, McLaine PN and the CPKDRC Co-investigator 1993 A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uremic syndrome. Epidemiol Infect 110: 1-7
22. Ruggenenti P, Lutz J, Remuzzi G 1997 Pathogenesis and treatment of thrombotic microangiopathy. Kidney Int 51: S97-S101
23. Schwartz G, Haycock GB, Edleman GM, Spitzer A 1976 A simple estimate of glomerular filtration in children derived from body length and plasma creatinine. Pediatrics 58: 259-263
24. Shimura M, Wada H, Wakita Y, Nakase T, Hiyiyama K, Nagaya A, Mori Y, Shiku H 1996 Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. Am J Hematol 52: 165-170
25. Takemura T, Yoshioka K, Akano N, Miyamoto H, Matsumoto K, Maki S 1987 Glomerular deposition of cross-linked fibrin in human kidney diseases. Kidney Int 32: 102-111
26. Taubman MB 1993 Tissue factor regulation in vascular smooth muscle: a summary of studies performed using in vitro and in vivo model. Am J Cardiol 72: 55C-60C